| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000031445 |
| Receipt No. | R000034719 |
| Official scientific title of the study | Comparison of Alogliptin and Metformin fixed-dose tablets once a morning vs. once an evening using Freestyle Libre Pro flash glucose Monitoring (AMPM study): An open-label randomized cross-over Trial. |
| Date of disclosure of the study information | 2018/02/23 |
| Last modified on | 2018/02/23 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Comparison of Alogliptin and Metformin fixed-dose tablets once a morning vs. once an evening using Freestyle Libre Pro flash glucose Monitoring (AMPM study): An open-label randomized cross-over Trial. | |
| Title of the study (Brief title) | Comparison of Alogliptin and Metformin fixed-dose tablets once a morning vs. once an evening using Freestyle Libre Pro flash glucose Monitoring (AMPM study): An open-label randomized cross-over Trial. | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the effect of alogliptin benzoate and metformin hydrochloride combination tablets medication at morning/night on blood glucose. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To compare the blood glucose area under the curve |
| Key secondary outcomes | 1) Average glucose (AG) 2) Average daily risk range (ADRR) 3) Morbus (M) value 4) 3-h post prandial (breakfast, lunch, dinner) blood glucose area under the curve (AUC) 5) Blood glucose (< 70mg/dl) area on the curve (AOC) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Morning treatment alogliptin benzoate and metformin hydrochloride combination tablets medication | ||
| Interventions/Control_2 | Evening treatment alogliptin benzoate and metformin hydrochloride combination tablets medication | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Age 20-70 years 2) Type 2 diabetes 3) HbA1c > 6.5% |
|||
| Key exclusion criteria | 1) Type 1 diabetes 2) Undergoing insulin or GLP-1 agonist treatment 3) shift worker or night worker 4) Contraindications of medicine (Cr => 1.3mg/dL for men and => 1.2mg/dL for women) 5) Patients have History of hyper sensitivity 6) Not suitable for paticipate in this study from medical reason judged by a doctor |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Ebara Futoshi |
| Organization | Iryohojin Sukoyaka Takadachuo Byoin |
| Division name | Department of the internal medicine |
| Address | 2-6-5 TakaKohokutanishi, Kohoku-Ku, Yokohama-City, Kanagawa, Japan |
| TEL | +81-45-592-5557 |
| japansk@nifty.com | |
| Public contact | |
| Name of contact person | Ebara Futoshi |
| Organization | Iryohojin Sukoyaka Takadachuo Byoin |
| Division name | Department of the internal medicine |
| Address | 2-6-5 TakaKohokutanishi, Kohoku-Ku, Yokohama-City, Kanagawa, Japan |
| TEL | +81-45-592-5557 |
| Homepage URL | |
| japansk@nifty.com | |
| Sponsor | |
| Institute | National Hospital Organization Kyoto Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034719 |